Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul><li>Zacks Small-Cap Research Note for Fibrobiologics (FBLG)</li></ul>

Zacks Small-Cap Research Note for Fibrobiologics (FBLG)

FBLG: Phase 1/2 Trial of CYWC628 Underway

<ul><li>Zacks Small-Cap Research Note for FibroBiologics, Inc. (FBLG)</li></ul>

Zacks Small-Cap Research Note for FibroBiologics, Inc. (FBLG)

FBLG US - CLPMF:  Clip Money Reports 81% Revenue Growth for Q1 2026 and Adds its First Bank Customer

United States

FibroBiologics, Inc. operates as an early stage, cell therapy company. The Company develops food and drug administration trials related to fibroblast treatments for degenerative disc disease, multiple sclerosis, cancer, wound healing, and other diseases. FibroBiologics serves clients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

FibroBiologics (FBLG US)

FBLG: Phase 1/2 Trial of CYWC628 Underway

Zacks Small-Cap Research Note for Fibrobiologics (FBLG)

Zacks Small Cap Research

FibroBiologics Inc -

Zacks Small-Cap Research Note for FibroBiologics, Inc. (FBLG)

Zacks Small Cap Research

FibroBiologics Inc -

Zacks Small-Cap Research Note for FibroBiologics, Inc. (FBLG)

Zacks Small Cap Research

FibroBiologics Inc -

Zacks Small-Cap Research Note for FibroBiologics, Inc. (FBLG)

Zacks Small Cap Research

FBLG US - CLPMF: Clip Money Reports 81% Revenue Growth for Q1 2026 and Adds its First Bank Customer

Zacks Small-Cap Research Note for FibroBiologics, Inc. (FBLG)

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)